Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Appointment strengthens the financial and corporate experience of Metrion’s Board in support of the Company’s planned international growth.
read more
Emmes announced today that Rhonda Henry has joined the company as President of Emmes BioPharma.
read more
CRISPR offerings to enhance NUVISAN’s drug development service portfolio.
read more
Inotiv, Inc announced today the Company’s plans to expand its St. Louis operations to provide more comprehensive and integrated services.
read more
Inotiv, Inc. announced today that the Company has entered into an agreement and plan of merger with Bolder BioPATH, Inc., a contract pharmacology and pathology company.
read more
Acquisition of A&C expands Aceto’s Western manufacturing footprint.
read more
Catalent announced today that it has made an investment to expand capabilities at its clinical supply services facility in Philadelphia to support sponsors developing cell and gene therapies.
read more
Additional contract broadens and further strengthens customer product portfolio.
read more
Further expands service offering to pharma and biotech customers.
read more
Wednesday, April 14, 2021
A Commercial State-of-the-art Research Laboratory Delivering Histopathology And Precision Medicine Services For Global Clinical Trials.
read more
Wednesday, April 14, 2021
Microbiologics has announced an additional 650 square foot Biosafety Level 3 (BSL-3) facility within its existing building at the company’s global headquarters in St. Cloud, Minnesota.
read more
Wednesday, April 14, 2021
Abzena has announced that the location of its new GMP manufacturing facility will be Sanford, North Carolina.
read more
Wednesday, April 14, 2021
Phase 1b/2a Study Expected to Begin In 2Q 2021.
read more
Wednesday, April 14, 2021
Centogene N.V. announced today that it has extended its partnership with Takeda Pharmaceutical Company Limited to diagnose patients with certain genetic disorders.
read more
Catalent announced today that it has completed the expansion of two new suites at its biologics drug substance development and manufacturing facility in Madison, Wisconsin.
read more